Published in Cancer Res on April 12, 2011
Quantitative modeling of chronic myeloid leukemia: insights from radiobiology. Blood (2012) 0.81
The effect of nilotinib plus arsenic trioxide on the proliferation and differentiation of primary leukemic cells from patients with chronic myoloid leukemia in blast crisis. Cancer Cell Int (2015) 0.75
Aberrant activation of CaMKIIγ accelerates chronic myeloid leukemia blast crisis. Leukemia (2016) 0.75
Dynamics of chronic myeloid leukaemia. Nature (2005) 6.63
In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc Natl Acad Sci U S A (1999) 5.65
The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol (1995) 4.77
Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer (2007) 3.63
The biology of CML blast crisis. Blood (2004) 3.59
Chronic myeloid leukaemia. Lancet (2007) 3.27
Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications. Nat Med (2006) 3.13
Tumor-stroma interactions. Curr Opin Genet Dev (2005) 2.89
Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood (2008) 2.76
Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype. Cancer Res (2009) 1.90
The stem cell niche. J Pathol (2009) 1.50
Cell-cell interaction networks regulate blood stem and progenitor cell fate. Mol Syst Biol (2009) 1.49
Tyrosine kinase inhibitor therapy can cure chronic myeloid leukemia without hitting leukemic stem cells. Haematologica (2009) 1.43
(A)symmetric stem cell replication and cancer. PLoS Comput Biol (2007) 1.36
Ionizing radiation and leukemia mortality among Japanese Atomic Bomb Survivors, 1950-2000. Radiat Res (2009) 1.34
Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia. Leuk Res (2008) 1.31
Dynamics and potential impact of the immune response to chronic myelogenous leukemia. PLoS Comput Biol (2008) 1.26
Treatment of chronic myeloid leukemia in blast crisis. Haematologica (2008) 1.25
BCR/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress. Leukemia (2008) 1.21
The Biology of CML blast crisis. Hematology Am Soc Hematol Educ Program (2007) 1.21
Phenotype of blasts in chronic myeloid leukemia in blastic phase-Analysis of bone marrow trephine biopsies and correlation with cytogenetics. Leuk Res (2008) 1.15
From adult stem cells to cancer stem cells: Oct-4 Gene, cell-cell communication, and hormones during tumor promotion. Ann N Y Acad Sci (2006) 1.13
The CML stem cell: evolution of the progenitor. Cell Cycle (2009) 1.10
Paradoxes in carcinogenesis: new opportunities for research directions. BMC Cancer (2007) 1.10
Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis. Radiat Res (1999) 1.06
New models for evaluation of radiation-induced lifetime cancer risk and its uncertainty employed in the UNSCEAR 2006 report. Radiat Res (2008) 1.05
Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib. PLoS Comput Biol (2009) 1.04
Chronic myelogenous leukemia showing biphenotypic blast crisis followed by lineage switch to B lymphoblastic leukemia. Leuk Res (2009) 0.99
Modeling imatinib-treated chronic myelogenous leukemia: reducing the complexity of agent-based models. Bull Math Biol (2007) 0.96
Stem cell regulatory niches and their role in normal and malignant hematopoiesis. Curr Opin Hematol (2010) 0.96
Hematopoiesis and its disorders: a systems biology approach. Blood (2010) 0.93
Modeling intercellular interactions during carcinogenesis. Radiat Res (2005) 0.89
Combination therapies against chronic myeloid leukemia: short-term versus long-term strategies. Cancer Res (2009) 0.87
A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction. J Theor Biol (2004) 0.86
Chronic myeloid leukemia blast crisis arises from progenitors. Stem Cells (2007) 0.86
Sudden onset of the blastic phase of chronic myelogenous leukemia: patterns and implications. Cancer (2003) 0.85
Quantitative approaches to analyzing imatinib-treated chronic myeloid leukemia. Trends Pharmacol Sci (2007) 0.84
Optimal control for resistance and suboptimal response in CML. Math Biosci (2010) 0.82
Stem cell regulation and the development of blast crisis in chronic myeloid leukemia: Implications for the outcome of Imatinib treatment and discontinuation. Med Hypotheses (2007) 0.82
Chronic myeloid leukemia: a model for oncology. Ann Hematol (2005) 0.81
Concurrent megakaryocytic and erythroid chronic myelogenous leukemia blast crisis. Arch Pathol Lab Med (2008) 0.81
Prognosis in chronic myeloid leukaemia: biology of the disease vs. treatment. Baillieres Clin Haematol (1987) 0.78
New experimental and theoretical investigations of hematopoietic stem cells and chronic myeloid leukemia. Blood Cells Mol Dis (2009) 0.77
[Immunophenotypes on blast cells of chronic myelogenous leukemia]. Nihon Rinsho (2001) 0.76
A randomized trial of epidural glucocorticoid injections for spinal stenosis. N Engl J Med (2014) 5.01
Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst (2002) 3.77
PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. J Clin Invest (2002) 2.31
Endostatin's antiangiogenic signaling network. Mol Cell (2004) 1.95
Design and synthesis of compounds that extend yeast replicative lifespan. Aging Cell (2006) 1.93
Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype. Cancer Res (2009) 1.90
Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant (2009) 1.87
Transcriptional network governing the angiogenic switch in human pancreatic cancer. Proc Natl Acad Sci U S A (2007) 1.85
Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. Proc Natl Acad Sci U S A (2004) 1.82
SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro. Cancer Res (2003) 1.53
Paradoxical dependencies of tumor dormancy and progression on basic cell kinetics. Cancer Res (2009) 1.46
Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects. Cancer Res (2003) 1.35
Ionizing radiation activates the Nrf2 antioxidant response. Cancer Res (2010) 1.35
Acute and fractionated irradiation differentially modulate glioma stem cell division kinetics. Cancer Res (2012) 1.25
Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis. FASEB J (2006) 1.21
Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis. J Theor Biol (2003) 1.16
Chromosomes are predominantly located randomly with respect to each other in interphase human cells. J Cell Biol (2002) 1.15
A new view of radiation-induced cancer: integrating short- and long-term processes. Part II: second cancer risk estimation. Radiat Environ Biophys (2009) 1.14
Molecular signaling network complexity is correlated with cancer patient survivability. Proc Natl Acad Sci U S A (2012) 1.13
A new view of radiation-induced cancer: integrating short- and long-term processes. Part I: approach. Radiat Environ Biophys (2009) 1.11
Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge. Vaccine (2006) 1.08
Endostatin: the logic of antiangiogenic therapy. Drug Resist Updat (2005) 1.07
Biological effects of proton radiation: what we know and don't know. Radiat Res (2013) 1.06
Cancer stem cells in solid tumors: is 'evading apoptosis' a hallmark of cancer? Prog Biophys Mol Biol (2011) 1.01
Non-stem cancer cell kinetics modulate solid tumor progression. Theor Biol Med Model (2011) 1.01
Intercellular communication by exchange of cytoplasmic material via tunneling nano-tube like structures in primary human renal epithelial cells. PLoS One (2011) 1.00
Investigations into the metabolism of two-dimensional colony and suspended microcarrier cultures of human embryonic stem cells in serum-free media. Stem Cells Dev (2010) 1.00
Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype. PLoS One (2012) 0.99
Climate change impacts on coral reefs: synergies with local effects, possibilities for acclimation, and management implications. Mar Pollut Bull (2013) 0.99
Cancer Stem Cells: A Minor Cancer Subpopulation that Redefines Global Cancer Features. Front Oncol (2013) 0.99
Radiation-induced leukemia at doses relevant to radiation therapy: modeling mechanisms and estimating risks. J Natl Cancer Inst (2006) 0.97
Second cancers after fractionated radiotherapy: stochastic population dynamics effects. J Theor Biol (2007) 0.96
An integrated multidisciplinary model describing initiation of cancer and the Warburg hypothesis. Theor Biol Med Model (2013) 0.95
Agitation can induce differentiation of human pluripotent stem cells in microcarrier cultures. Tissue Eng Part C Methods (2010) 0.94
The tumor growth paradox and immune system-mediated selection for cancer stem cells. Bull Math Biol (2012) 0.93
Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cells. Stem Cell Res Ther (2014) 0.92
Tumor morphological evolution: directed migration and gain and loss of the self-metastatic phenotype. Biol Direct (2010) 0.91
Systems biology and its potential role in radiobiology. Radiat Environ Biophys (2007) 0.90
Proton irradiation suppresses angiogenic genes and impairs cell invasion and tumor growth. Radiat Res (2012) 0.90
Prospective identification of glioblastoma cells generating dormant tumors. PLoS One (2012) 0.90
Quantitative modeling of tumor dynamics and radiotherapy. Acta Biotheor (2010) 0.89
Modeling intercellular interactions during carcinogenesis. Radiat Res (2005) 0.89
The emerging "hallmarks" of metabolic reprogramming and immune evasion: distinct or linked? Cancer Res (2013) 0.89
High incidence of unusual cysteine variants in gp120 envelope proteins from early HIV type 1 infections from a Phase 3 vaccine efficacy trial. AIDS Res Hum Retroviruses (2006) 0.88
Whole blood transcriptomics in cardiac surgery identifies a gene regulatory network connecting ischemia reperfusion with systemic inflammation. PLoS One (2010) 0.87
Age and space irradiation modulate tumor progression: implications for carcinogenesis risk. Radiat Res (2013) 0.87
Transcriptional changes induced by the tumor dormancy-associated microRNA-190. Transcription (2013) 0.87
Stochastic population dynamic effects for lung cancer progression. Radiat Res (2009) 0.86
Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy. Arterioscler Thromb Vasc Biol (2013) 0.85
Tumor-immune dynamics regulated in the microenvironment inform the transient nature of immune-induced tumor dormancy. Cancer Res (2013) 0.84
Two Endogenous Antiangiogenic Inhibitors, Endostatin and Angiostatin, Demonstrate Biphasic Curves in their Antitumor Profiles. Dose Response (2010) 0.83
Center of cancer systems biology second annual workshop--tumor metronomics: timing and dose level dynamics. Cancer Res (2013) 0.83
Immunoediting: evidence of the multifaceted role of the immune system in self-metastatic tumor growth. Theor Biol Med Model (2012) 0.83
NASA Radiation Biomarker Workshop, September 27-28, 2007. Radiat Res (2008) 0.82
Systems biology of tumor dormancy: linking biology and mathematics on multiple scales to improve cancer therapy. Cancer Res (2012) 0.82
Novel translocation in acute megakaryoblastic leukemia (AML-M7). J Pediatr Hematol Oncol (2003) 0.82
Disparities in the use of radiation therapy in patients with local-regionally advanced breast cancer. Int J Radiat Oncol Biol Phys (2010) 0.81
Quantitative modeling of chronic myeloid leukemia: insights from radiobiology. Blood (2012) 0.81
Impact of vitronectin concentration and surface properties on the stable propagation of human embryonic stem cells. Biointerphases (2010) 0.81
Identification of stable endogenous control genes for transcriptional profiling of photon, proton and carbon-ion irradiated cells. Radiat Oncol (2012) 0.81
Adjuvant external beam radiation for medullary thyroid carcinoma. J Surg Oncol (2010) 0.81
Using graph theory to describe and model chromosome aberrations. Radiat Res (2002) 0.80
Combined therapy with sonic hedgehog gene transfer and bone marrow-derived endothelial progenitor cells enhances angiogenesis and myogenesis in the ischemic skeletal muscle. J Vasc Res (2012) 0.80
Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers. J Theor Biol (2013) 0.80
Multiple effects of β-amyloid on single excitatory synaptic connections in the PFC. Front Cell Neurosci (2013) 0.80
3D microcarrier system for efficient differentiation of human pluripotent stem cells into hematopoietic cells without feeders and serum [corrected]. Regen Med (2013) 0.80
The promoting role of a tumour-secreted chemorepellent in self-metastatic tumour progression. Math Med Biol (2010) 0.80
Antiangiogenic therapy and p53. Science (2002) 0.80
Chronic low dose-rate radiation down-regulates transcription related to mitosis and chromosomal movement similar to acute high dose in prostate cells. Int J Radiat Biol (2014) 0.79
Pentostatin - pharmacology, immunology, and clinical effects in graft-versus-host disease. Expert Opin Pharmacother (2004) 0.79
Cancer Therapy Targeting the HER2-PI3K Pathway: Potential Impact on the Heart. Front Pharmacol (2012) 0.79
Mannitol infusion within 15 min of cross-clamp improves living donor kidney preservation. Transplantation (2014) 0.78
Sustained first remission in an adolescent with hepatosplenic T-cell lymphoma treated with T-cell leukemia induction, nucleoside analog-based consolidation, and early hematopoietic stem cell transplant. Pediatr Blood Cancer (2009) 0.78
Sonic hedgehog therapy in a mouse model of age-associated impairment of skeletal muscle regeneration. J Gerontol A Biol Sci Med Sci (2013) 0.78
Repopulation of interacting tumor cells during fractionated radiotherapy: stochastic modeling of the tumor control probability. Med Phys (2013) 0.78